Panel Discussion: What Is the Best Management of MR-Percutaneous Valve Repair or Replacement?

Sunday, February 26, 2023

11:37 AM – 12:00 PM ET

Panel Moderator(s)

Kendra J. Grubb, MD

Surgical Director, Structural Heart and Valve Center
Emory University
Atlanta, Georgia, United States

Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)
Scott Lim, MD

Professor of Medicine & Pediatrics
University of Virginia
Charlottesville, Virginia, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Opus: Consultant/Advisory Board (Ongoing); Phillips: Scientific Advisory Board (Ongoing); Valgen: Consultant (Ongoing); Venus Medtech: Consultant (Ongoing)
MN

Mamoo Nakamura, MD (he/him/his)

Associate Director, Cardiac Catheterization Laboratory and Interventional Cardiology
Smidt Heart Institute, Cedars-Sinai Medical Center

No relationships to disclose

Panel Discussant(s)

Itsik Ben-Dor, MD

WHC
MedStar Washington Hospital Center
Washington, District of Columbia, United States

No relationships to disclose
Brian Bethea, MD

Chief Cardiac Surgery MUMH
MedStar Union Memorial Hospital
Phoenix, Maryland, United States

Disclosure(s): Abbott: Clinical Trial Investigator (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing)
Mayra E. Guerrero, MD, FACC, FSCAI

Professor of Medicine
Mayo Clinic Hospital
Rochester, Minnesota, United States

Disclosure(s): Edward Lifesciences: Grant/Research Support (Ongoing)
Howard C. Herrmann, MD, FACC, MSCAI

Director, Interventional Cardiology and Cardiac Cath Labs
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Samir R. Kapadia, MD, FSCAI

Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): No relevant disclosure to display
Vlasis Ninios, MD

interventional cardiologist, Director of cardiology department
Interbalkan European Medical center
Thessaloniki , Greece

Disclosure(s): No financial relationships to disclose
Michael J. Reardon, MD

Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States

Disclosure(s): Abbott Medical: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Medtronic: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)
Chet Rihal, MD

Physician
Mayo Clinic
Rochester, Minnesota, United States

No relationships to disclose
Jonathan G. Schwartz, MD (he/him/his)

Medical Director, Interventional Cardiology
Sanger Heart & Vascular Institute/Atrium Health

Disclosure(s): Abbott Inc: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing), Scientific Research Study Investigator (Ongoing); Boston Scientific: Advisor (Ongoing), Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Scientific Research Study Investigator (Ongoing); Cordis Corporation: Advisor (Ongoing), Consultant/Advisory Board (Ongoing), Scientific Advisory Board (Ongoing); Edwards Lifesciences: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing), Scientific Research Study Investigator (Ongoing); Medtronic Inc: Advisor (Ongoing), Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Scientific Research Study Investigator (Ongoing); WL Gore & Associates: Advisor (Ongoing), Scientific Research Study Investigator (Ongoing)
Paul Sorajja, MD

Director, Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital
Abbott Northwestern Hospital
Minneapolis, Minnesota, United States

Disclosure(s): Abbott Structural, Medtronic, Boston Scientific, vDyne, WL Gore, Shifamed, xDot, Anteris: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Kendra J. Grubb, MD: 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

Scott Lim, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Opus: Consultant/Advisory Board (Ongoing); Phillips: Scientific Advisory Board (Ongoing); Valgen: Consultant (Ongoing); Venus Medtech: Consultant (Ongoing)

Raj Makkar, MD, FSCAI: Abbott: Grant/Research Support (Ongoing); Cedars-Sinai Medical Center: Employee (Ongoing); Cordis: Consultant (Ongoing); Edwards Lifesciences: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Consultant (Ongoing)

Brian Bethea, MD: Abbott: Clinical Trial Investigator (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing)

Mayra E. Guerrero, MD, FACC, FSCAI: Edward Lifesciences: Grant/Research Support (Ongoing)

Howard C. Herrmann, MD, FACC, MSCAI: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)

Samir R. Kapadia, MD, FSCAI: No relevant disclosure to display

Vlasis Ninios, MD: No financial relationships to disclose

Michael J. Reardon, MD: Abbott Medical: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Medtronic: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

Jonathan G. Schwartz, MD: Abbott Inc: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing), Scientific Research Study Investigator (Ongoing); Boston Scientific: Advisor (Ongoing), Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Scientific Research Study Investigator (Ongoing); Cordis Corporation: Advisor (Ongoing), Consultant/Advisory Board (Ongoing), Scientific Advisory Board (Ongoing); Edwards Lifesciences: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing), Scientific Research Study Investigator (Ongoing); Medtronic Inc: Advisor (Ongoing), Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Scientific Research Study Investigator (Ongoing); WL Gore & Associates: Advisor (Ongoing), Scientific Research Study Investigator (Ongoing)

Paul Sorajja, MD: Abbott Structural, Medtronic, Boston Scientific, vDyne, WL Gore, Shifamed, xDot, Anteris: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing)

Vinod Thourani, MD, FACC, FACS: Abbott Vascular, Artivion, Edwards, Boston Scientific, Jenavalve, Shockwave: Advisor (Ongoing); DASI Simulations: Intellectual Property/Patents (Ongoing)